Keyphrases
Irreversible Electroporation
100%
Photoacoustic Lifetime Imaging
87%
Methylene Blue
66%
Tumor
64%
Tissue Oxygenation
62%
Photoacoustic
48%
Focal Therapy
44%
Iron Oxide Nanoparticles
40%
Small Animal
39%
Cryosurgery
37%
Oxygen Monitoring
37%
Hypoxia
35%
In Vivo Imaging
32%
Thermal Ablation
30%
Photoacoustic Imaging
29%
Photoacoustic Probe
28%
Hindlimb
27%
Inductive Heating
25%
Polymer Scaffold
25%
Nanowarming
25%
Mouse Tumor Model
25%
Cryopreservation
25%
Activatable Probe
25%
Electrical Properties Tomography
25%
Electrical Properties
25%
Cryoprotectant
23%
Photodynamic Therapy
22%
Contrast Imaging
21%
Oxygen Sensitivity
21%
Prostate Cancer
21%
Magnetic Nanoparticles
19%
Imaging Modalities
19%
Immune Checkpoint Inhibitors
18%
Dual-labeling
17%
Hyperthermia Treatment
17%
Silica-coated Iron Oxide Nanoparticles
17%
Mesoporous Silica
17%
Biodistribution
16%
VS55
15%
Focal Ablation
15%
Anti-PD-1 Immunotherapy
15%
Cancer Treatment
15%
Ex Vivo Tissues
15%
Clinical Trials
15%
Preclinical Research
15%
Research Trials
15%
Miniature Probe
15%
Oxygen Level
14%
Protein Denaturation
14%
Oxygen Imaging
14%
Medicine and Dentistry
Neoplasm
89%
Lifespan
75%
Irreversible Electroporation
37%
Tomography
37%
Immunotherapy
25%
Photochemotherapy
25%
Hypoxia
19%
Immune Checkpoint Inhibitor
18%
Prostate Cancer
16%
Magnetic Resonance Imaging
16%
Tumor Model
15%
Tumor Hypoxia
14%
Cryosurgery
12%
Tumor Antigen
12%
Heat Therapy
12%
Cytotoxic T-Cell
12%
Ultrasmall Superparamagnetic Iron Oxide
12%
Biodistribution
12%
T1 Contrast
12%
Pancreas Cancer
12%
Iron Oxide
12%
Electrical Mapping
12%
Mouse Model of Cancer
12%
Clinical Trial
12%
Treatment Response
12%
Cryopreservation
12%
Hexachlorophene
12%
Hindlimb
11%
Specific Tumor
9%
Lymphatic Tissue
9%
Carbene
9%
Tumor Progression
9%
Diseases
8%
Malignant Neoplasm
8%
Radiofrequency Coil
8%
Breast Cancer
7%
In Vitro
7%
Medicine
7%
Ex Vivo
7%
Cancer Cell
7%
Photoacoustic Imaging
6%
Cancer Immunotherapy
6%
Breathing
6%
CTLA-4
6%
Hyperthermia
6%
Photosensitizer
5%
Hypoxemia
5%
Needle Electrode
5%
Xenograft
5%
Combination Therapy
5%